ArticleHematology reports2024

Efficacy of Anti-CD38 Monoclonal Antibodies for Relapsed or Refractory Multiple Myeloma in Stem Cell Transplant-Ineligible Patients Aged over 65 Years: A Propensity Score-Matched Study.

Satoshi Yamasaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.